Since targeting DEC-205 in the absence of DC activation/maturation agents had previously been described to result in tolerance, the ability of fd bacteriophages to induce a strong tumor specific immune response by targeting DCs through DEC-205 further validate the potential employment of this safe, versatile and inexpensive delivery system for vaccine formulation. Here, ELP1 is linked to neoplasm.